Melanotan 2 (10mg)

Additional Info

Properties

• Tesamorelin Chemical Formula: C50H69N15O9
• Tesamorelin Molecular Weight: 1024.2 g/mol
• Tesamorelin Sequence: Ac-Nle-cyclo [Asp-His-D-Phe-Arg-Trp-Lys]-NH2
• Total Amount of the Active Ingredient: 10mg (1 vial)
• Shelf Life: 36 months

Shipping

• USA
• Canada
• Seizure Policy (International Orders): If your shipment is seized, we offer a 50% discount on your next purchase. Contact us for details.

Disclaimer

The information provided does not substitute medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider for medical concerns. Never delay seeking medical advice based on information read or seen. We do not assume responsibility or liability for any use of our research compounds and products. These are intended for research purposes ONLY. Personal use is not condoned.

Additional Label & Product Information

Important Warning:

These chemicals are strictly for research or laboratory use and are not FDA-approved for human consumption.

Usage Instructions:

• Avoid contact with skin and eyes. In case of contact, wash thoroughly with water.
• Seek medical help if you feel unwell or accidental ingestion occurs.
• Store the lyophilized (freeze-dried) peptide at room temperature immediately upon receipt.
• Avoid frequent freeze-thaw cycles to maintain peptide stability.

Product Disclaimer:

This product is not intended to diagnose, treat, cure, or prevent any disease. Use only as directed by your specific research or laboratory protocol.

Resources

1. Wensink D, Wagenmakers MAEM, Langendonk JG. Afamelanotide is used to prevent phototoxicity in people with erythropoietic protoporphyria. It was reviewed in Expert Review of Clinical Pharmacology in February 2021.
2. Koikov L, Starner RJ, Swope VB, et al. Researchers developed selective small agonists for the hMC1R receptor to facilitate sunless tanning and protect melanocytes from UV-induced genotoxicity. This study was published in the Journal of Investigative Dermatology in July 2021.
3. Lau JKY, Tian M, Shen Y, et al. Activation of melanocortin receptors was found to alleviate amyloid pathology and reduce glial reactivity in a mouse model of Alzheimer’s disease. The findings were reported in Scientific Reports in February 2021.
4. Carmo JM, da Silva AA, Wang Z, et al. The role of brain melanocortins in regulating blood pressure was explored in Biochimica et Biophysica Acta in October 2017.
5. Ahmed TJ, Montero-Melendez T, Perretti M, et al. The anti-inflammatory effects of melanocortin peptides through endogenous pathways were discussed in the International Journal of Inflammation in 2013.
6. Wurtman R. The potential role of melatonin in managing multiple sclerosis and other neurobehavioral diseases was reviewed in Frontiers in Endocrinology in October 2017.
7. Sande PH, Dorfman D, Fernandez DC, et al. Melatonin treatment was shown to attenuate ocular inflammation in an experimental uveitis model. This research was published in the British Journal of Pharmacology in December 2014.
8. Strader AD, Shi H, Ogawa R, et al. The effects of the melanocortin agonist MT-II on adipose tissue in rodents were investigated in the Journal of Pharmacology and Experimental Therapeutics in September 2007.